Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvano Adami

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Echocardiography (Mount Kisco, N.Y.)|February 20, 2016
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid ArthritisGiovanni Cioffi, Ombretta Viapiana, Federica Ognibeni, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatibThomas M Rünger, Silvano Adami, Claude-Laurent Benhamou, et al.
Arthritis Research & Therapy|December 1, 2010
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disabilityMaurizio Rossini, Susanna Maddali Bongi, Giovanni La Montagna, et al.
Advances in Therapy|July 26, 2018
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED StudyPiercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|July 12, 2012
The initiative on hip fractures of the Veneto RegionMaurizio Rossini, Cristian Caimmi, Sandro Giannini, et al.
International Immunopharmacology|December 22, 2016
CD14<sup>++</sup> CD16<sup>-</sup> monocytes are the main source of 11β-HSD type 1 after IL-4 stimulationVidya Kunnathully, Macarena Gomez-Lira, Giulio Bassi, et al.
Transplantation|June 23, 2011
Densitometric threshold and vertebral fractures in heart transplant patientsLuca Dalle Carbonare, Mirko Zanatta, Vania Braga, et al.
Archives of Internal Medicine|October 13, 2004
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosisRobert Lindsay, Wim H Scheele, Robert Neer, et al.
Journal of Hypertension|August 4, 2015
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac diseaseGiovanni Cioffi, Ombretta Viapiana, Federica Ognibeni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral densityRichard Eastell, Dennis M Black, Steven Boonen, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Echocardiography (Mount Kisco, N.Y.)|February 20, 2016
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid ArthritisGiovanni Cioffi, Ombretta Viapiana, Federica Ognibeni, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatibThomas M Rünger, Silvano Adami, Claude-Laurent Benhamou, et al.
Arthritis Research & Therapy|December 1, 2010
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disabilityMaurizio Rossini, Susanna Maddali Bongi, Giovanni La Montagna, et al.
Advances in Therapy|July 26, 2018
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED StudyPiercarlo Sarzi-Puttini, Emilio Filippucci, Silvano Adami, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|July 12, 2012
The initiative on hip fractures of the Veneto RegionMaurizio Rossini, Cristian Caimmi, Sandro Giannini, et al.
International Immunopharmacology|December 22, 2016
CD14<sup>++</sup> CD16<sup>-</sup> monocytes are the main source of 11β-HSD type 1 after IL-4 stimulationVidya Kunnathully, Macarena Gomez-Lira, Giulio Bassi, et al.
Transplantation|June 23, 2011
Densitometric threshold and vertebral fractures in heart transplant patientsLuca Dalle Carbonare, Mirko Zanatta, Vania Braga, et al.
Archives of Internal Medicine|October 13, 2004
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosisRobert Lindsay, Wim H Scheele, Robert Neer, et al.
Journal of Hypertension|August 4, 2015
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac diseaseGiovanni Cioffi, Ombretta Viapiana, Federica Ognibeni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral densityRichard Eastell, Dennis M Black, Steven Boonen, et al.
Pageof 13